Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 522.73 million compared to CNY 570.8 million a year ago. Revenue was CNY 526.47 million compared to CNY 578.32 million a year ago.

Net income was CNY 32.45 million compared to CNY 285.88 million a year ago. Basic earnings per share from continuing operations was CNY 0.2704 compared to CNY 2.3823 a year ago. Diluted earnings per share from continuing operations was CNY 0.2704 compared to CNY 2.3823 a year ago.